Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis
Clinical trial NCT02641457 · COMPLETED
Trial details
- NCT number
- NCT02641457
- Sponsor
- Instituto de Olhos de Goiania
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.